• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form S-8 POS filed by Marrone Bio Innovations Inc.

    8/3/22 9:57:45 PM ET
    $MBII
    Major Chemicals
    Basic Industries
    Get the next $MBII alert in real time by email
    S-8 POS 1 tm2222485d7_s8pos.htm S-8 POS

     

    As filed with the United States Securities and Exchange Commission on August 3, 2022

     

    Registration No. 333-251970

    Registration No. 333-237322

    Registration No. 333-232039

    Registration No. 333-229859

    Registration No. 333-225401

    Registration No. 333-222846

    Registration No. 333-219981

    Registration No. 333-191048

     

     

     

    UNITED STATES 

    SECURITIES AND EXCHANGE COMMISSION 

    Washington, D.C. 20549

     

    Post-Effective Amendment No. 1 to:

    Form S-8 Registration Statement No. 333-251970

    Form S-8 Registration Statement No. 333-237322

    Form S-8 Registration Statement No. 333-232039

    Form S-8 Registration Statement No. 333-229859

    Form S-8 Registration Statement No. 333-225401

    Form S-8 Registration Statement No. 333-222846

    Form S-8 Registration Statement No. 333-219981

    Form S-8 Registration Statement No. 333-191048

     

    UNDER 

    THE SECURITIES ACT OF 1933

     

    PRO FARM GROUP, INC.

    (Formerly known as Marrone Bio Innovations, Inc.)

    (Exact Name of Registrant as Specified in its Charter)

     

    Delaware 20-5137161
    (State or other jurisdiction of
    incorporation or organization)
    (I.R.S. Employer
    Identification No.)

     

    7780-420 Brier Creek Parkway  
    Raleigh, North Carolina 27617
    (Address of principal executive offices) (Zip Code)

     

    Marrone Bio Innovations, Inc. 2019 Employee Stock Purchase Plan

    Marrone Bio Innovations, Inc. 2013 Stock Incentive Plan, As Amended

    Marrone Bio Innovations, Inc. 2013 Stock Incentive Plan

    Marrone Bio Innovations, Inc. 2011 Stock Plan

    Marrone Bio Innovations, Inc. Stock Option Plan

    (Full title of the plans)

     

    Federico Trucco Chief Executive Officer

    7780-420 Brier Creek Parkway

    Raleigh, North Carolina 27617

    (Name, and address of agent for service)

     

    (530) 750-2800

    (Telephone number, including area code, for agent for service)

     

    Copies to:

     

    Matthew S. Poulter, Esq.
    Pierre-Emmanuel Perais, Esq.

    Linklaters LLP

    1290 Avenue of the Americas
    New York, NY 10104
    (212) 903-9000

     

    Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

     

    Large accelerated filer ¨

    Accelerated filer ¨

    Non-accelerated filer x

     

    Smaller reporting company x

    Emerging growth company ¨

     

    If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act. ¨

     

     

     

     

     

     

    EXPLANATORY NOTE/DEREGISTRATION OF SECURITIES

     

    This Post-Effective Amendment (this “Post-Effective Amendment”) relates to the following Registration Statements on Form S-8 (each, a “Registration Statement” and collectively, the “Registration Statements”) previously filed by Pro Farm Group, Inc. (formerly known as Marrone Bio Innovations, Inc.), a Delaware corporation (the “Registrant”), with the U.S. Securities and Exchange Commission (the “SEC”):

     

    1. Registration Statement on Form S-8 (No. 333-251970), filed with the SEC on January 8, 2021, pertaining to the registration of 5,861,741 shares of the Registrant’s common stock, par value $0.00001 per share (the “Shares”) for issuance under the Registrant’s 2013 Stock Incentive Plan, as amended;
       
    2. Registration Statement on Form S-8 (No. 333-237322), filed with the SEC on March 20, 2020, pertaining to the registration of 4,883,425 Shares for issuance under the Registrant’s 2013 Stock Incentive Plan, as amended;
       
    3. Registration Statement on Form S-8 (No. 333-232039), filed with the SEC on June 7, 2019, pertaining to the registration of 1,000,000 Shares for issuance under the Registrant’s 2019 Employee Stock Purchase Plan;

     

    4. Registration Statement on Form S-8 (No. 333-229859), filed with the SEC on February 25, 2019, pertaining to the registration of 3,874,168 Shares for issuance under the Registrant’s 2013 Stock Incentive Plan, as amended;
       
    5. Registration Statement on Form S-8 (No. 333-225401), filed with the SEC on June 1, 2018, pertaining to the registration of 3,500,000 Shares for issuance under the Registrant’s 2013 Stock Incentive Plan, as amended;
       
    6. Registration Statement on Form S-8 (No. 333-222846), filed with the SEC on February 2, 2018, pertaining to the registration of 5,097,281 Shares for issuance under the Registrant’s 2013 Stock Incentive Plan, as amended;
       
    7. Registration Statement on Form S-8 (No. 333-219981), filed with the SEC on August 15, 2017, pertaining to the registration of 3,254,467Shares for issuance under the Registrant’s 2013 Stock Incentive Plan; and
       
    8.

    Registration Statement on Form S-8 (No. 333-191048), filed with the SEC on September 6, 2013, pertaining to the registration of 1,928,614 Shares for issuance under the Registrant’s 2013 Stock Incentive Plan, of 1,173,660 Shares for issuance under the Registrant’s 2011 Stock Plan, and of 885,636 Shares for issuance under the Registrant’s Stock Option Plan, as amended.

     

    The Registrant is filing this Post-Effective Amendment to its Registration Statements to withdraw and remove from registration the securities of the Registrant that had been registered but remain unsold or not yet issued under such Registration Statements. 

     

    On July 13, 2022, pursuant to and in accordance with the Agreement and Plan of Merger, dated as of March 16, 2022 (the “Merger Agreement”), by and among the Registrant, Bioceres Crop Solutions Corp. (“Parent”), and BCS Merger Sub, Inc. (“Merger Sub”), a wholly-owned subsidiary of Parent, Merger Sub merged with and into the Registrant (the “Merger”), with the Registrant surviving the Merger as a wholly-owned subsidiary of Parent. 

     

    As a result of the Merger, the Registrant has terminated all offerings of securities pursuant to the Registration Statements. Accordingly, the Registrant, by filing this Post-Effective Amendment, hereby terminates the effectiveness of each of the Registration Statements and, in accordance with undertakings made by the Registrant in the Registration Statements to remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering, removes from registration any and all securities of the Registrant registered but unsold under the Registration Statements as of the date hereof.

     

     

     

     

    SIGNATURE

     

    Pursuant to the requirements of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Post-Effective Amendment to the Registration Statements described above to be signed on its behalf by the undersigned, thereunto duly authorized, in the City of Raleigh, State of North Carolina, on August 3, 2022.

     

    PRO FARM GROUP, INC.

    (Formerly known as Marrone Bio Innovations, Inc.)

     

     

    By: /s/ Federico Trucco  
      Name: Federico Trucco  
      Title: Chief Executive Officer  

     

    No other person is required to sign this Post-Effective Amendment to the Registration Statements in reliance on Rule 478 of the Securities Act of 1933, as amended.

     

     

     

    Get the next $MBII alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $MBII

    DatePrice TargetRatingAnalyst
    9/22/2021$2.00Buy
    Roth Capital
    8/19/2021$3.50 → $2.50Buy
    Aegis Capital
    More analyst ratings

    $MBII
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • SEC Form 4: Vasavada Amit was granted 129,184 shares and returned 285,892 shares to the company, closing all direct ownership in the company

      4 - MARRONE BIO INNOVATIONS INC (0001441693) (Issuer)

      7/15/22 11:15:05 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • SEC Form 4: Johnson Timothy B was granted 102,167 shares and returned 212,374 shares to the company, closing all direct ownership in the company

      4 - MARRONE BIO INNOVATIONS INC (0001441693) (Issuer)

      7/15/22 11:13:32 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • SEC Form 4 filed by Ospraie Ag Science Llc

      4 - MARRONE BIO INNOVATIONS INC (0001441693) (Issuer)

      7/15/22 9:09:02 AM ET
      $MBII
      Major Chemicals
      Basic Industries

    $MBII
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • Roth Capital initiated coverage on Marrone Bio Innovations with a new price target

      Roth Capital initiated coverage of Marrone Bio Innovations with a rating of Buy and set a new price target of $2.00

      9/22/21 11:59:03 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • Aegis Capital reiterated coverage on Marrone Bio Innovations with a new price target

      Aegis Capital reiterated coverage of Marrone Bio Innovations with a rating of Buy and set a new price target of $2.50 from $3.50 previously

      8/19/21 9:34:56 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • Canaccord Genuity resumed coverage on Marrone Bio Innovations with a new price target

      Canaccord Genuity resumed coverage of Marrone Bio Innovations with a rating of Buy and set a new price target of $3.50

      3/5/21 7:31:59 AM ET
      $MBII
      Major Chemicals
      Basic Industries

    $MBII
    Financials

    Live finance-specific insights

    See more
    • Marrone Bio Innovations, Inc. Reports First-Quarter 2022 Financial Results

      RALEIGH, N.C., May 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the first quarter ended March 31, 2022. Key results include: Higher sales of row crop products in the first quarter were somewhat offset by lower sales into specialty crop markets, which were affected by adverse weather conditions. Based on the strength of current orders, revenues in the first half are expected to increase in the low- to mid-teens on a percentage basis.Gross profit of $6.2 million and gross margins of 55.9% reflected changes in product mix, higher raw material

      5/11/22 4:01:00 PM ET
      $BIOX
      $MBII
      Agricultural Chemicals
      Industrials
      Major Chemicals
      Basic Industries
    • Marrone Bio Innovations to Report First Quarter 2022 Results on Wednesday, May 11 at 4:30 p.m. Eastern Time

      RALEIGH, N.C., April 27, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, will release financial results for the first quarter ended March 31, 2022, after market close on Wednesday, May 11, 2022. Management will host an investor conference call at 4:30 p.m. ET to discuss Marrone Bio Innovations' first quarter financial results, provide a corporate update, and conclude with a Q&A from participants. To participate, please use the following information: Q1 2022 Conference Call and Webcast Date: Wednesday, May 11, 2022Time: 4:30 p.m

      4/27/22 8:00:00 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • Marrone Bio Innovations, Inc. Reports Fourth-Quarter and Full-Year 2021 Financial Results

      RALEIGH, N.C., March 28, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII), an international leader in sustainable bioprotection and plant health solutions, has provided its financial results for the fourth quarter and full year ended December 31, 2021. Key results include: Full year revenues rose 15.5%, with a 40.2% increase in the fourth quarter.Gross profit grew 19.1% and 31.5% for the full year and fourth quarter, respectively, with margins exceeding 59% in both periods.For the full year, net loss was $16.6 million and Adjusted EBITDA1 loss was $8.7 million, improvements of 17.9% and 21.2%, respectively.As announced March 16, 2022, Marrone Bio and Bioceres Crop So

      3/28/22 4:01:00 PM ET
      $BIOX
      $MBII
      Agricultural Chemicals
      Industrials
      Major Chemicals
      Basic Industries

    $MBII
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D/A filed by Marrone Bio Innovations Inc. (Amendment)

      SC 13D/A - MARRONE BIO INNOVATIONS INC (0001441693) (Subject)

      7/15/22 9:12:06 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • SEC Form SC 13G/A filed by Marrone Bio Innovations Inc. (Amendment)

      SC 13G/A - MARRONE BIO INNOVATIONS INC (0001441693) (Subject)

      3/29/22 11:21:42 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • SEC Form SC 13G/A filed by Marrone Bio Innovations Inc. (Amendment)

      SC 13G/A - MARRONE BIO INNOVATIONS INC (0001441693) (Subject)

      2/14/22 12:25:35 PM ET
      $MBII
      Major Chemicals
      Basic Industries

    $MBII
    SEC Filings

    See more
    • SEC Form 15-12G filed by Marrone Bio Innovations Inc.

      15-12G - Pro Farm Group, Inc. (0001441693) (Filer)

      9/2/22 6:17:10 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • SEC Form EFFECT filed by Marrone Bio Innovations Inc.

      EFFECT - Pro Farm Group, Inc. (0001441693) (Filer)

      8/30/22 12:15:26 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • SEC Form EFFECT filed by Marrone Bio Innovations Inc.

      EFFECT - Pro Farm Group, Inc. (0001441693) (Filer)

      8/30/22 12:15:28 AM ET
      $MBII
      Major Chemicals
      Basic Industries

    $MBII
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • ROTH MKM's Agribusiness Investment Banking Group Sees Success with the Closing of Three M&A Sellside Transactions

      ROTH MKM ("Roth"), www.roth.com, a relationship-driven investment bank focused on serving growth companies and their investors, is pleased to announce that their agribusiness investment banking group has advised on three sellside transactions in the past nine months. The transactions included business models in the areas of cover crops, gene editing, biologicals, bio stimulants, and alternative fertilizers, and demonstrate the group's expertise in designing and executing M&A processes to achieve the best outcomes for its clients in a wide array of agriculture related sectors. ROTH MKM's Agribusiness Investment Banking Group served as the sellside advisor on the following transactions:

      4/11/23 9:00:00 AM ET
      $BG
      $BIOX
      $CTVA
      $CVX
      Packaged Foods
      Consumer Staples
      Agricultural Chemicals
      Industrials
    • Bioceres Crop Solutions Completes Merger With Marrone Bio, Creating a Global Leader in Sustainable Agricultural Solutions

      Bioceres Crop Solutions Corp. (NASDAQ:BIOX) ("Bioceres" or the "Company"), a fully integrated provider of crop productivity solutions designed to enable the transition of agriculture towards carbon neutrality, announced today the successful completion of its previously announced integration of Marrone Bio Innovations, Inc. (NASDAQ:MBII) ("MBI"). "The completion of this transaction represents an important milestone in our journey, cementing our leadership in the development and commercialization of sustainable agricultural solutions," said Bioceres Chief Executive Officer, Federico Trucco. "MBI brings 15 years of experience in the development of biological solutions, and we are excited to a

      7/12/22 4:43:00 PM ET
      $BIOX
      $MBII
      Agricultural Chemicals
      Industrials
      Major Chemicals
      Basic Industries
    • Marrone Bio Innovations, Inc. Shareholders Approve Merger Agreement with Bioceres Crop Solutions Corp.

      RALEIGH, N.C., July 11, 2022 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ:MBII) (MBI) announced that during a special shareholder meeting held on July 8, 2022, its shareholders approved a proposal to adopt the previously announced Agreement and Plan of Merger (Merger Agreement), dated as of March 16, 2022, by and among Bioceres Crop Solutions Corp. (BIOX), BCS Merger Sub, Inc., and MBI, pursuant to which MBI will be acquired by BIOX. At the special meeting, MBI's stockholders approved the adoption of the Merger Agreement and approved on a non-binding advisory basis certain executive compensation that may be paid or become payable in connection with the merger contemplated by t

      7/11/22 8:30:00 AM ET
      $BIOX
      $MBII
      Agricultural Chemicals
      Industrials
      Major Chemicals
      Basic Industries

    $MBII
    Leadership Updates

    Live Leadership Updates

    See more
    • 180 Life Sciences Corp. Announces the Appointment of Pamela Marrone, PhD and Frank Knuettel II, MBA to Board of Directors

      MENLO PARK, Calif., June 10, 2021 (GLOBE NEWSWIRE) -- 180 Life Sciences Corp. (NASDAQ: ATNF) (180 Life Sciences or the "Company"), a clinical-stage biotechnology company focused on the development of novel drugs that fulfill unmet needs in inflammatory diseases, fibrosis and pain, today announced that it has appointed Pamela Marrone, PhD, and Frank Knuettel II, MBA, to its Board of Directors (“Board”) effective upon the earlier of (a) the business day following the filing of the 2020 Form 10-K Annual Report; and (b) June 28, 2021. The Board also changed the effective dates of the appointments of Russell T. Ray, MBA and Teresa DeLuca MD, MBA as members of the Board, as previously announced

      6/10/21 9:12:32 AM ET
      $MBII
      Major Chemicals
      Basic Industries
    • Marrone Bio Appoints Sue Cheung New Chief Financial Officer

      DAVIS, Calif., Jan. 28, 2021 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (NASDAQ: MBII), an international leader in providing growers with sustainable bioprotection and plant health solutions to support global agricultural needs, announced today that Suping (Sue) Cheung has been appointed chief financial officer, effective Feb. 18, 2021. She succeeds James Boyd, who previously announced his intention to retire. Cheung, a certified public accountant, brings to Marrone Bio 28 years of experience in international strategic and financial operations, including financial reporting, forecasting and budgeting; mergers and acquisitions; equity and debt financing; internal controls; and inves

      1/28/21 9:00:00 AM ET
      $QUIK
      $MBII
      Semiconductors
      Technology
      Major Chemicals
      Basic Industries